Evidence map›Paper›PMID 36719556›Full record

ReviewJournal of nephrology2023

Muscle fat infiltration in chronic kidney disease: a marker related to muscle quality, muscle strength and sarcopenia.

Carla Maria Avesani, Aline Miroski de Abreu, Heitor S Ribeiro, Torkel B Brismar, Peter Stenvinkel, Alice Sabatino, Bengt Lindholm

Registry-linked trialOpen access · hybridAbstract readReview
In one paragraph

Review in Journal of nephrology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT06631820 (The Effect of the Nutraceutical), which is not on this map. Cited by 48 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 3 pooled it
11.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06631820 narecruitingnot on this mapstarted 2025, after this paper: background citation

The Effect of the Nutraceutical (-)- Epicatechin on Myosteatosis in Patients With Advanced CKD: a Pilot Study (EPIC-CKD)

TypeinterventionalSponsorKarolinska InstitutetRan2025 to 2026Enrolled10ConditionsChronic Kidney Disease(CKD), Myosteatosis, Mitochondrial Dysfunction, Muscle FunctionArmsEpicatechin extract
3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 3 syntheses or guidelines pooled it, 65 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
  6. Adverse Muscle Composition Is Associated with All-Cause Mortality in CKD: A UK Biobank Imaging Study.Clinical journal of the American Society of Nephrology : CJASN · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Article
  17. Multiparametric quantitative magnetic resonance imaging of skeletal muscle in CKD.American journal of physiology. Renal physiology · 2025
    Article
  18. Article
  19. Obesity and Metabolic Health in CKD.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 4 countries.

Carla Maria AvesaniDivision of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, M99, Karolinska Hospital University Hospital Huddinge, 14186, Stockholm, Sweden. carla.avesani@ki.se.ORCID http://orcid.org/0000-0002-4458-8358
Aline Miroski de AbreuPost-Graduate Program in Nutrition, Department of Nutrition, Federal University of Santa Catarina, Florianopolis, Brazil.ORCID http://orcid.org/0000-0003-0006-8999
Heitor S RibeiroFaculty of Health Sciences, University of Brasilia, Brasília, Brazil.ORCID http://orcid.org/0000-0002-4019-4490
Torkel B BrismarUnit of Radiology, Department of Clinical Sciences, Intervention and Technology, Karolinska Institute, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-3409-1938
Peter StenvinkelDivision of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, M99, Karolinska Hospital University Hospital Huddinge, 14186, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8785-4820
Alice SabatinoDepartment of Nephrology, Parma University Hospital, Parma, Italy.ORCID http://orcid.org/0000-0003-2098-7597
Bengt LindholmDivision of Renal Medicine, Baxter Novum, Department of Clinical Science, Intervention and Technology, Karolinska Institute, M99, Karolinska Hospital University Hospital Huddinge, 14186, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-4269-4293
Karolinska University Hospital · SEUniversidade de Brasília · BRUniversidade Federal de Santa Catarina · BRUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Muscle fat infiltration (MFI) also known as myosteatosis refers to any deposit of lipids found in the skeletal muscle. MFI is preferably assessed by image-based methods like computed tomography (CT), magnetic resonance image (MRI) and ultrasound, normally from muscle groups located in the legs, arms and in the trunk. MFI is understood as a marker of muscle quality, where a muscle with higher fat deposition has lower contraction power and capacity to produce force per unit of muscle mass. This concept supports the hypothesis that a decrease in muscle strength is not always explained by a decrease in muscle mass, but also by other factors, including lipid deposition in the muscle. In the general population, MFI is associated with older age, physical inactivity and with insulin resistance and inflammation. In chronic kidney disease (CKD), MFI has been associated with a decrease in muscle strength and impaired muscle quality as well as with metabolic abnormalities, cardiovascular disease and increased mortality. Interventions aimed at reducing MFI in CKD are incipient, but it seems that guided exercise can ameliorate muscle quality in patients on hemodialysis. The aim of this narrative review about MFI in CKD is to draw attention to a still not often addressed complication in CKD. We conclude that more studies are warranted to investigate mechanisms and factors promoting MFI in CKD. Thus, clinical trials aimed at understanding the type, frequency and intensity of exercise that can diminish MFI and improve the clinical condition of the patients are needed.

Indexed as

Renal Insufficiency, ChronicSarcopeniaHumansMuscle, SkeletalMuscle StrengthRenal DialysisChronic kidney diseaseDialysisMuscle fat infiltrationMuscle qualityMyosteatosisSarcopenia

Identifiers

PMID36719556
PMCPMC10090035
OpenAlexW4318669280

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.